-
CD58 Loss in Tumor Cells Confers Functional Impairment of CAR T-cells
Yan et al, Blood Advances 2022
-
Multidimensional Single-Cell Analysis Identifies a Role of CD2-CD58 Interactions for Clinical Antitumor T-Cell Responses
Romain et al, bioRxiv 2022
-
Multi-Modal Pooled Perturb-Cite-Seq Screens in Patient Models Define Novel Mechanisms of Cancer Immune Evasion
Frangieh et al, Nat Genet 2021
-
CD58 Aberrations Limit Durable Responses to CD19 CAR in Large B Cell Lymphoma Patients Treated with Axicabtagene Ciloleucel but Can be Overcome through Novel CAR Engineering
Majzner et al, Nature Medicine 2019
-
Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell Lymphoma
Challa-Malladi et al, Cancer Cell 2011
Publications
Outsmarting cancer to address
cancer resistance mechanisms
